Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Major

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
ACS Chemical Biology|November 16, 2021
Visualizing an Allosteric Intermediate Using CuAAC Stabilization of an NMR Mixed Labeled DimerPaul J Sapienza, Michelle M Currie, Noah M Lancaster, et al.
Cytoskeleton (Hoboken, N.J.)|September 4, 2019
The MyMOMA domain of MYO19 encodes for distinct Miro-dependent and Miro-independent mechanisms of interaction with mitochondrial membranesJennifer L Bocanegra, Barbara M Fujita, Natalie R Melton, et al.
The Journal of Biological Chemistry|November 10, 2018
Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagusJunsheng Fu, Zhaohui Xiong, Caizhi Huang, et al.
Science Signaling|September 6, 2012
FAM123A binds to microtubules and inhibits the guanine nucleotide exchange factor ARHGEF2 to decrease actomyosin contractilityPriscila F Siesser, Marta Motolese, Matthew P Walker, et al.
The Journal of Biological Chemistry|June 1, 2017
The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasomeJason J Yi, Smita R Paranjape, Matthew P Walker, et al.
Cancer Research|December 11, 2013
Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitinationBridgid E Hast, Erica W Cloer, Dennis Goldfarb, et al.
Chemical Research in Toxicology|August 24, 2014
Ginger compound [6]-shogaol and its cysteine-conjugated metabolite (M2) activate Nrf2 in colon epithelial cells in vitro and in vivoHuadong Chen, Junsheng Fu, Hao Chen, et al.
The Journal of Biological Chemistry|January 5, 2012
Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 proteinNathan D Camp, Richard G James, David W Dawson, et al.
Nature Communications|November 14, 2024
Author Correction: A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesisYanzhe Gao, Elizabeth Mutter-Rottmayer, Alicia M Greenwalt, et al.
F1000Research|February 21, 2014
FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cellsWillliam Conrad, Michael B Major, Michele A Cleary, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
ACS Chemical Biology|November 16, 2021
Visualizing an Allosteric Intermediate Using CuAAC Stabilization of an NMR Mixed Labeled DimerPaul J Sapienza, Michelle M Currie, Noah M Lancaster, et al.
Cytoskeleton (Hoboken, N.J.)|September 4, 2019
The MyMOMA domain of MYO19 encodes for distinct Miro-dependent and Miro-independent mechanisms of interaction with mitochondrial membranesJennifer L Bocanegra, Barbara M Fujita, Natalie R Melton, et al.
The Journal of Biological Chemistry|November 10, 2018
Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagusJunsheng Fu, Zhaohui Xiong, Caizhi Huang, et al.
Science Signaling|September 6, 2012
FAM123A binds to microtubules and inhibits the guanine nucleotide exchange factor ARHGEF2 to decrease actomyosin contractilityPriscila F Siesser, Marta Motolese, Matthew P Walker, et al.
The Journal of Biological Chemistry|June 1, 2017
The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasomeJason J Yi, Smita R Paranjape, Matthew P Walker, et al.
Cancer Research|December 11, 2013
Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitinationBridgid E Hast, Erica W Cloer, Dennis Goldfarb, et al.
Chemical Research in Toxicology|August 24, 2014
Ginger compound [6]-shogaol and its cysteine-conjugated metabolite (M2) activate Nrf2 in colon epithelial cells in vitro and in vivoHuadong Chen, Junsheng Fu, Hao Chen, et al.
The Journal of Biological Chemistry|January 5, 2012
Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 proteinNathan D Camp, Richard G James, David W Dawson, et al.
Nature Communications|November 14, 2024
Author Correction: A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesisYanzhe Gao, Elizabeth Mutter-Rottmayer, Alicia M Greenwalt, et al.
F1000Research|February 21, 2014
FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cellsWillliam Conrad, Michael B Major, Michele A Cleary, et al.
Pageof 9